Literature DB >> 14584118

Ruptured renal artery stump aneurysm in a renal autotransplanted Behçet's disease patient.

Tae-Won Kwon1, Do-Kyun Kim, SunMo Yang, Kyu-Bo Sung, Geun-Eun Kim.   

Abstract

A recurrent aneurysm at the anastomosis site or the remaining artery frequently occurs after the operative treatment of an aneurysm in Behçet's disease despite anti-inflammatory medication. Herein, a ruptured left renal artery stump aneurysm in a patient with Behçet's disease, who received a left nephrectomy, aorto-biiliac bypass and heterotopic autotransplantation of the right kidney for the treatment of an abdominal aortic aneurysm and renal hypertension one year prior to this admission, is reported. An aneurysm and rupture occurred despite the administration of anti-inflammatory medications while monitoring of the clinical findings, such as skin manifestations, erythrocyte segmentation rate (ESR) and C-reactive protein (CRP). Although there is no definite proven treatment modality to prevent recurrent aneurysms at the anastomosis site or a remote artery, close follow-up with anti-inflammatory medications, and surveillance with regular intervals are the only current methods for the prevention and/or to treatment of an arterial complication in patients with Behçet's disease.

Entities:  

Mesh:

Year:  2003        PMID: 14584118     DOI: 10.3349/ymj.2003.44.5.943

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  2 in total

1.  Successfully treated isolated renal artery pseudoaneurysm in a patient with Behçet's disease.

Authors:  Sihyung Park; Ga Hee Lee; Jin Han Park; Bong Soo Park; Kyubok Jin; Yang Wook Kim
Journal:  Kidney Res Clin Pract       Date:  2015-09-28

Review 2.  Spontaneous Intra-Abdominal Hemorrhage Due to Rupture of Jejunal Artery Aneurysm in Behcet Disease: Case Report and Literature Review.

Authors:  Xiao-Yan Wu; Jiang-Peng Wei; Xiu-Yuan Zhao; Yue Wang; Huan-Huan Wu; Tao Shi; Tong Liu; Gang Liu
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.